Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan;33(1):99-100.
doi: 10.1097/ICO.0000000000000022.

Resolution of conjunctival sessile hemangioma with topical timolol

Affiliations
Review

Resolution of conjunctival sessile hemangioma with topical timolol

Jordon G Lubahn et al. Cornea. 2014 Jan.

Abstract

Purpose: To report a single case of acquired sessile hemangioma of the conjunctiva which resolved after treatment with topical timolol.

Methods: Case report and literature review.

Results: A 77-year-old African American woman developed an acquired sessile hemangioma of the conjunctiva of the right eye. She was followed for primary open-angle glaucoma, and the lesion was monitored for 12 months without change. Topical timolol-dorzolamide was then added to her glaucoma medication regimen twice daily. On follow-up examination 6 months later, the lesion had completely resolved.

Conclusions: In this case report, an acquired sessile hemangioma of the conjunctiva resolved with topical timolol therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Acquired sessile hemangioma of the conjunctiva of a 77-year old African-American woman. A—Lesion as seen before treatment. B—Resolution 6 months after starting topical dorzolamide-timolol with only trace residual vessel irregularity remaining.

References

    1. Shields JA, Kligman BE, Mashayekhi A, et al. Acquired sessile hemangioma of the conjunctiva: a report of 10 cases. Am J Ophthalmol. 2011;152:55–59. - PubMed
    1. Shields JA, Mashayekhi A, Kligman BE, et al. Vascular tumors of the conjunctiva in 140 cases. Ophthalmology. 2011;118:1747–53. - PubMed
    1. Drolet BA, Frommelt PC, Chamlin SL, et al. Initiation and use of propranolol for infantile hemangioma: report of a consensus conference. Pediatrics. 2013;131:128–40. - PMC - PubMed
    1. Guo S, Ni N. Topical treatment for capillary hemangioma of the eyelid using beta-blocker solution. Arch Ophthalmol. 2010;128:255–6. - PubMed
    1. Chakkittakandiyil A, Phillips R, Frieden IJ, et al. Timolol maleate 0.5% or 0.1% gel-forming solution for infantile hemangiomas: a retrospective, multicenter, cohort study. Pediatr Dermatol. 2012;29:28–31. - PubMed

Publication types